TP53 and B-cell chronic lymphocytic leukemia: In accordance with this, Fabbri et al. [155] showed that miR-15a/16-1 cluster was linked in a molecular pathway with p53 that explained the pathogenic and prognostic implications (indolent vs. aggressive form) of recurrent 13q, 17p deletions in B-CLL.